ESTRELLA IMMUNOPHARMA INC (ESLA) Stock Income Statement
NASDAQ:ESLA - Nasdaq - US2975841048 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2024 (2024-6-30) | 2023 (2022-12-31) | 2022 (2021-12-31) | 2021 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 8.82M | 7.31M | 1.57M | 250.00K | 250.00K | |||
| Research and Development | 6.45M | 4.11M | 10.45M | 1.39M | N/A | |||
| Selling, General, and Administrative Expenses | 2.36M | 3.20M | 200.00K | 70.00K | 70.00K | |||
| Operating Income | -8.82M | -7.31M | -1.57M | -250.00K | 0.00 | |||
| Interest Income/Expense | N/A | N/A | 650.00K | 0.00 | 0.00 | |||
| Income Before Taxes | -8.82M | -7.31M | -920.00K | -250.00K | -250.00K | |||
| Income Tax | 1.63K | 1.63K | 80.00K | 0.00 | 0.00 | |||
| Net Income | -8.82M | -7.31M | -1.00M | -250.00K | -250.00K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.24 | -0.20 | -0.43 | -0.21 | -0.21 | |||
| Statistics | ||||||||
All data in USD